Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jan 21, 2008; 14(3): 329-330
Published online Jan 21, 2008. doi: 10.3748/wjg.14.329
Published online Jan 21, 2008. doi: 10.3748/wjg.14.329
What’s new in inflammatory bowel disease in 2008?
Daniel C Baumgart, Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Center-Virchow Hospital, Medical School of the Humboldt-University of Berlin, D-13353 Berlin, Germany
Correspondence to: Dr. Daniel C Baumgart, MD, PhD, Division of Gastroenterology and Hepatology, Department of Medicine, Charité Medical Center-Virchow Hospital, Medical School of the Humboldt-University of Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany. daniel.baumgart@charite.de
Telephone: +49-30-450553277
Fax: +49-30-450553983
Received: May 16, 2007
Revised: June 28, 2007
Published online: January 21, 2008
Revised: June 28, 2007
Published online: January 21, 2008
Abstract
Ulcerative colitis and Crohn’s disease represent the two major forms of inflammatory bowel disease. In this highlight topic series of articles we cover the latest developments in genetics and epidemiology, intestinal physiology, mucosal immunology, mechanisms of epithelial cell injury and restitution, current medical therapy, modern surgical management, important extra-intestinal complications such as primary sclerosing cholangitis, cholangiocellular carcinoma and autoimmune hepatitis as well as endoscopic and molecular screening, detection and prevention of small bowel and colorectal cancer.
Keywords: Crohn’s disease; Ulcerative colitis; Inflammatory bowel disease; Immunology; Genetics; Epidemiology; Medical therapy; Surgery; Cancer; Extra-intestinal manifestations